<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02070133</url>
  </required_header>
  <id_info>
    <org_study_id>EC08/00123</org_study_id>
    <nct_id>NCT02070133</nct_id>
  </id_info>
  <brief_title>Efficacy of Simvastatin for the Treatment of COPD</brief_title>
  <official_title>Pilot Study on the Efficacy of Statins for the Treatment of Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Son Dureta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundació d'investigació Sanitària de les Illes Balears</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cimera</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari Son Dureta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate in patients with stable Chronic Obstructive Pulmonary Disease (COPD) the efficacy
      of statins (simvastatin) on: (1) endothelial function; (2) systemic inflammation; (3)BODE (B:
      body mass , O: bronchial obstruction, D: dyspnea and, E: exercise tolerance) index; (4) Uric
      acid; and, (5)vascular growth factors. Design: a 12 weeks randomized (1:1), double-blind,
      placebo control study. Population: 18 males with stable COPD between 40-80 years of age,
      exsmokers, with Forced expiratory volume in one second (FEV1) between 30 and 80% predicted
      post-bronchodilation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial Dysfunction (Arterial Stiffness)</measure>
    <time_frame>Day 1 and day 84 (end of of week 12)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systemic inflammation</measure>
    <time_frame>Day 1 and day 84 (end of of week 12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BODE index</measure>
    <time_frame>Day 1 and day 84 (end of of week 12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uric acid</measure>
    <time_frame>Day 1 and day 84 (end of of week 12)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular growth factors</measure>
    <time_frame>Day 1 and day 84 (end of of week 12)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Simvastatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with COPD will receive simvastatin 40 mg once a day for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients with COPD will receive placebo once a day during 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simvastatin</intervention_name>
    <description>Simvastatin 40 mg once a day during 12 weeks</description>
    <arm_group_label>Simvastatin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo once a day during 12 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable COPD between 40-80 years of age, exsmokers, with FEV1 lower that 80% predicted
             post-bronchodilation.

        Exclusion Criteria:

          -  Severe co-morbidity (advanced-stage cancer, tuberculosis affecting more than a third
             of the total lung parenchyma, pneumonectomy, pneumoconiosis, left cardiac failure
             previously reported, known cardiopathy with ventricular dysfunction (ejection fraction
             &lt; 45%) or any cardiovascular disease, Diabetes Mellitus treated with insulin,
             Hypercholesterolemia, Chronic inflammatory diseases (asthma, rheumatoid arthritis,
             lung fibrosis, autoimmune diseases), Treatment with systemic steroid, non steroidal
             anti-inflammatory drugs or stains within 3 months prior to inclusion.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ernest Sala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Son Espases, Palma Mallorca</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fundacio Caubet-CIMERA</name>
      <address>
        <city>Bunyola</city>
        <state>Illes Balears</state>
        <zip>07110</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Son Espases</name>
      <address>
        <city>Palma Mallorca</city>
        <state>Illes Balears</state>
        <zip>07010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2013</study_first_submitted>
  <study_first_submitted_qc>February 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2014</study_first_posted>
  <last_update_submitted>February 21, 2014</last_update_submitted>
  <last_update_submitted_qc>February 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Son Espases</investigator_affiliation>
    <investigator_full_name>Ernest Sala</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Chronic Bronchitis</keyword>
  <keyword>Statins</keyword>
  <keyword>Endothelial dysfunction</keyword>
  <keyword>Systemic inflammation</keyword>
  <keyword>BODE index</keyword>
  <keyword>Uric acid</keyword>
  <keyword>Vascular growth factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

